Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Glenmark Pharmaceuticals Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Glenmark Pharmaceuticals Ltd. market cap is 647.66B.
What is the 52-week high for Glenmark Pharmaceuticals Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Glenmark Pharmaceuticals Ltd. 52 week high is 2,474.00 as of July 17, 2026.
What is the 52-week low for Glenmark Pharmaceuticals Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Glenmark Pharmaceuticals Ltd. 52 week low is 1,792.60 as of July 17, 2026.
What is Glenmark Pharmaceuticals Ltd. stock price today?
Glenmark Pharmaceuticals Ltd. stock price today is 2,290.00.
What was Glenmark Pharmaceuticals Ltd. stock price yesterday?
Glenmark Pharmaceuticals Ltd. stock price yesterday was 2,304.20.
What is the PE ratio of Glenmark Pharmaceuticals Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Glenmark Pharmaceuticals Ltd.'s P/E ratio is 47.39.
What is the Price-to-Book ratio of Glenmark Pharmaceuticals Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Glenmark Pharmaceuticals Ltd. P/B ratio is 6.7353.
What is the 50-day moving average of Glenmark Pharmaceuticals Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Glenmark Pharmaceuticals Ltd. 50-day moving average is 2,250.57.